Asparagine synthetase (ASNS) Drives Tumorigenicity in Small Cell Lung Cancer

Minho Jeong, Beom Chang Kim, Hyoung Jin Choi, Gyu Tae Lee, Sang-Min Jang, Kee-Beom Kim · 2025

Read Asparagine synthetase (ASNS) Drives Tumorigenicity in Small Cell Lung Cancer by Minho Jeong, Beom Chang Kim, Hyoung Jin Choi, Gyu Tae Lee, Sang-Min Jang, Kee-Beom Kim (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12731195.txt.

Description

Minho Jeong and co-authors report a study from two thousand twenty-five on an enzyme that fuels small cell lung cancer. This cancer grows fast, spreads early, and answers poorly to treatment. Tumors rewire their metabolism to keep up, and the team asked which enzymes do the heavy lifting.

The enzyme, asparagine synthetase, makes the amino acid asparagine. Its levels ran much higher in small cell tumors than in normal lung or other lung cancers. Silencing it in mouse and human cancer cells slowed growth and colony formation. In mice, tumors with the enzyme knocked down grew less and hosts lived longer. The authors argue the enzyme helps the cancer adapt metabolically, making it a candidate drug target.

Catalog record

CREATORMinho Jeong, Beom Chang Kim, Hyoung Jin Choi, Gyu Tae Lee, Sang-Min Jang, Kee-Beom Kim
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE41 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12731195

Browse the full library · About the Tower of Babel